4d
AZoLifeSciences on MSNGene Delivery Systems: Viral vs. Non-Viral VectorsThis article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...
Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...
Explore a comprehensive guide to standardizing large scale production and clarification of lentiviral vectors.
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...
BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV) vector. The company’s lead gene therapy, BV-702, is AAV-based and is in preclinical development for ...
Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the ...
Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...
Results show improved functional outcomes for people with Duchenne muscular dystrophy who are ambulatory. Elevidys, which is ...
The Tokyo-based biotech firm expects RV-001 to be able to alter light sensitivity for patients with limited or no vision regardless of genotype.
Using “cure” to refer to “obtaining a normal life” also fits — if you ignore previously lost education, career opportunities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results